Pain Management Drugs Market - Global Outlook and Forecast 2021-2027

Publisher Name :
Date: 09-Sep-2021
No. of pages: 109

This report contains market size and forecasts of Pain Management Drugs in Global, including the following market information:

Global Pain Management Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Pain Management Drugs market was valued at 35970 million in 2020 and is projected to reach US$ 37230 million by 2027, at a CAGR of 0.9% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pain Management Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pain Management Drugs Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Pain Management Drugs Market Segment Percentages, By Type, 2020 (%)

- Generic Opioids

- Branded Opioids

- NSAIDs

- Others

China Pain Management Drugs Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Pain Management Drugs Market Segment Percentages, By Application, 2020 (%)

- Hospitals

- Drugstores

- Others

Global Pain Management Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Pain Management Drugs Market Segment Percentages, By Region and Country, 2020 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Pain Management Drugs Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Pain Management Drugs Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

- GSK

- Pfizer

- Grunenthal

- Sanofi

- Bayer

- AstraZeneca

- Eli Lilly

- Endo

- Merck

- Yunnan Baiyao

- Teikoku Seiyaku

- Teva

- J&J

- Assertio Therapeutics

- Allergan

Pain Management Drugs Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Pain Management Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pain Management Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pain Management Drugs Overall Market Size
2.1 Global Pain Management Drugs Market Size: 2021 VS 2027
2.2 Global Pain Management Drugs Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pain Management Drugs Players in Global Market
3.2 Top Global Pain Management Drugs Companies Ranked by Revenue
3.3 Global Pain Management Drugs Revenue by Companies
3.4 Top 3 and Top 5 Pain Management Drugs Companies in Global Market, by Revenue in 2020
3.5 Global Companies Pain Management Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pain Management Drugs Players in Global Market
3.6.1 List of Global Tier 1 Pain Management Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Pain Management Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pain Management Drugs Market Size Markets, 2021 & 2027
4.1.2 Generic Opioids
4.1.3 Branded Opioids
4.1.4 NSAIDs
4.1.5 Others
4.2 By Type - Global Pain Management Drugs Revenue & Forecasts
4.2.1 By Type - Global Pain Management Drugs Revenue, 2016-2021
4.2.2 By Type - Global Pain Management Drugs Revenue, 2022-2027
4.2.3 By Type - Global Pain Management Drugs Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pain Management Drugs Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Drugstores
5.1.4 Others
5.2 By Application - Global Pain Management Drugs Revenue & Forecasts
5.2.1 By Application - Global Pain Management Drugs Revenue, 2016-2021
5.2.2 By Application - Global Pain Management Drugs Revenue, 2022-2027
5.2.3 By Application - Global Pain Management Drugs Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Pain Management Drugs Market Size, 2021 & 2027
6.2 By Region - Global Pain Management Drugs Revenue & Forecasts
6.2.1 By Region - Global Pain Management Drugs Revenue, 2016-2021
6.2.2 By Region - Global Pain Management Drugs Revenue, 2022-2027
6.2.3 By Region - Global Pain Management Drugs Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Pain Management Drugs Revenue, 2016-2027
6.3.2 US Pain Management Drugs Market Size, 2016-2027
6.3.3 Canada Pain Management Drugs Market Size, 2016-2027
6.3.4 Mexico Pain Management Drugs Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Pain Management Drugs Revenue, 2016-2027
6.4.2 Germany Pain Management Drugs Market Size, 2016-2027
6.4.3 France Pain Management Drugs Market Size, 2016-2027
6.4.4 U.K. Pain Management Drugs Market Size, 2016-2027
6.4.5 Italy Pain Management Drugs Market Size, 2016-2027
6.4.6 Russia Pain Management Drugs Market Size, 2016-2027
6.4.7 Nordic Countries Pain Management Drugs Market Size, 2016-2027
6.4.8 Benelux Pain Management Drugs Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Pain Management Drugs Revenue, 2016-2027
6.5.2 China Pain Management Drugs Market Size, 2016-2027
6.5.3 Japan Pain Management Drugs Market Size, 2016-2027
6.5.4 South Korea Pain Management Drugs Market Size, 2016-2027
6.5.5 Southeast Asia Pain Management Drugs Market Size, 2016-2027
6.5.6 India Pain Management Drugs Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Pain Management Drugs Revenue, 2016-2027
6.6.2 Brazil Pain Management Drugs Market Size, 2016-2027
6.6.3 Argentina Pain Management Drugs Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pain Management Drugs Revenue, 2016-2027
6.7.2 Turkey Pain Management Drugs Market Size, 2016-2027
6.7.3 Israel Pain Management Drugs Market Size, 2016-2027
6.7.4 Saudi Arabia Pain Management Drugs Market Size, 2016-2027
6.7.5 UAE Pain Management Drugs Market Size, 2016-2027
7 Players Profiles
7.1 GSK
7.1.1 GSK Corporate Summary
7.1.2 GSK Business Overview
7.1.3 GSK Pain Management Drugs Major Product Offerings
7.1.4 GSK Pain Management Drugs Revenue in Global (2016-2021)
7.1.5 GSK Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Pain Management Drugs Major Product Offerings
7.2.4 Pfizer Pain Management Drugs Revenue in Global (2016-2021)
7.2.5 Pfizer Key News
7.3 Grunenthal
7.3.1 Grunenthal Corporate Summary
7.3.2 Grunenthal Business Overview
7.3.3 Grunenthal Pain Management Drugs Major Product Offerings
7.3.4 Grunenthal Pain Management Drugs Revenue in Global (2016-2021)
7.3.5 Grunenthal Key News
7.4 Sanofi
7.4.1 Sanofi Corporate Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Pain Management Drugs Major Product Offerings
7.4.4 Sanofi Pain Management Drugs Revenue in Global (2016-2021)
7.4.5 Sanofi Key News
7.5 Bayer
7.5.1 Bayer Corporate Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Pain Management Drugs Major Product Offerings
7.5.4 Bayer Pain Management Drugs Revenue in Global (2016-2021)
7.5.5 Bayer Key News
7.6 AstraZeneca
7.6.1 AstraZeneca Corporate Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Pain Management Drugs Major Product Offerings
7.6.4 AstraZeneca Pain Management Drugs Revenue in Global (2016-2021)
7.6.5 AstraZeneca Key News
7.7 Eli Lilly
7.7.1 Eli Lilly Corporate Summary
7.7.2 Eli Lilly Business Overview
7.7.3 Eli Lilly Pain Management Drugs Major Product Offerings
7.4.4 Eli Lilly Pain Management Drugs Revenue in Global (2016-2021)
7.7.5 Eli Lilly Key News
7.8 Endo
7.8.1 Endo Corporate Summary
7.8.2 Endo Business Overview
7.8.3 Endo Pain Management Drugs Major Product Offerings
7.8.4 Endo Pain Management Drugs Revenue in Global (2016-2021)
7.8.5 Endo Key News
7.9 Merck
7.9.1 Merck Corporate Summary
7.9.2 Merck Business Overview
7.9.3 Merck Pain Management Drugs Major Product Offerings
7.9.4 Merck Pain Management Drugs Revenue in Global (2016-2021)
7.9.5 Merck Key News
7.10 Yunnan Baiyao
7.10.1 Yunnan Baiyao Corporate Summary
7.10.2 Yunnan Baiyao Business Overview
7.10.3 Yunnan Baiyao Pain Management Drugs Major Product Offerings
7.10.4 Yunnan Baiyao Pain Management Drugs Revenue in Global (2016-2021)
7.10.5 Yunnan Baiyao Key News
7.11 Teikoku Seiyaku
7.11.1 Teikoku Seiyaku Corporate Summary
7.11.2 Teikoku Seiyaku Business Overview
7.11.3 Teikoku Seiyaku Pain Management Drugs Major Product Offerings
7.11.4 Teikoku Seiyaku Pain Management Drugs Revenue in Global (2016-2021)
7.11.5 Teikoku Seiyaku Key News
7.12 Teva
7.12.1 Teva Corporate Summary
7.12.2 Teva Business Overview
7.12.3 Teva Pain Management Drugs Major Product Offerings
7.12.4 Teva Pain Management Drugs Revenue in Global (2016-2021)
7.12.5 Teva Key News
7.13 J&J
7.13.1 J&J Corporate Summary
7.13.2 J&J Business Overview
7.13.3 J&J Pain Management Drugs Major Product Offerings
7.13.4 J&J Pain Management Drugs Revenue in Global (2016-2021)
7.13.5 J&J Key News
7.14 Assertio Therapeutics
7.14.1 Assertio Therapeutics Corporate Summary
7.14.2 Assertio Therapeutics Business Overview
7.14.3 Assertio Therapeutics Pain Management Drugs Major Product Offerings
7.14.4 Assertio Therapeutics Pain Management Drugs Revenue in Global (2016-2021)
7.14.5 Assertio Therapeutics Key News
7.15 Allergan
7.15.1 Allergan Corporate Summary
7.15.2 Allergan Business Overview
7.15.3 Allergan Pain Management Drugs Major Product Offerings
7.15.4 Allergan Pain Management Drugs Revenue in Global (2016-2021)
7.15.5 Allergan Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Pain Management Drugs Market Opportunities & Trends in Global Market
Table 2. Pain Management Drugs Market Drivers in Global Market
Table 3. Pain Management Drugs Market Restraints in Global Market
Table 4. Key Players of Pain Management Drugs in Global Market
Table 5. Top Pain Management Drugs Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Pain Management Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Pain Management Drugs Revenue Share by Companies, 2016-2021
Table 8. Global Companies Pain Management Drugs Product Type
Table 9. List of Global Tier 1 Pain Management Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pain Management Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Pain Management Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Pain Management Drugs Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Pain Management Drugs Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Pain Management Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Pain Management Drugs Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Pain Management Drugs Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Pain Management Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Pain Management Drugs Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Pain Management Drugs Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Pain Management Drugs Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Pain Management Drugs Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Pain Management Drugs Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Pain Management Drugs Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Pain Management Drugs Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Pain Management Drugs Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Pain Management Drugs Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Pain Management Drugs Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Pain Management Drugs Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Pain Management Drugs Revenue, (US$, Mn), 2022-2027
Table 30. GSK Corporate Summary
Table 31. GSK Pain Management Drugs Product Offerings
Table 32. GSK Pain Management Drugs Revenue (US$, Mn), (2016-2021)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Pain Management Drugs Product Offerings
Table 35. Pfizer Pain Management Drugs Revenue (US$, Mn), (2016-2021)
Table 36. Grunenthal Corporate Summary
Table 37. Grunenthal Pain Management Drugs Product Offerings
Table 38. Grunenthal Pain Management Drugs Revenue (US$, Mn), (2016-2021)
Table 39. Sanofi Corporate Summary
Table 40. Sanofi Pain Management Drugs Product Offerings
Table 41. Sanofi Pain Management Drugs Revenue (US$, Mn), (2016-2021)
Table 42. Bayer Corporate Summary
Table 43. Bayer Pain Management Drugs Product Offerings
Table 44. Bayer Pain Management Drugs Revenue (US$, Mn), (2016-2021)
Table 45. AstraZeneca Corporate Summary
Table 46. AstraZeneca Pain Management Drugs Product Offerings
Table 47. AstraZeneca Pain Management Drugs Revenue (US$, Mn), (2016-2021)
Table 48. Eli Lilly Corporate Summary
Table 49. Eli Lilly Pain Management Drugs Product Offerings
Table 50. Eli Lilly Pain Management Drugs Revenue (US$, Mn), (2016-2021)
Table 51. Endo Corporate Summary
Table 52. Endo Pain Management Drugs Product Offerings
Table 53. Endo Pain Management Drugs Revenue (US$, Mn), (2016-2021)
Table 54. Merck Corporate Summary
Table 55. Merck Pain Management Drugs Product Offerings
Table 56. Merck Pain Management Drugs Revenue (US$, Mn), (2016-2021)
Table 57. Yunnan Baiyao Corporate Summary
Table 58. Yunnan Baiyao Pain Management Drugs Product Offerings
Table 59. Yunnan Baiyao Pain Management Drugs Revenue (US$, Mn), (2016-2021)
Table 60. Teikoku Seiyaku Corporate Summary
Table 61. Teikoku Seiyaku Pain Management Drugs Product Offerings
Table 62. Teikoku Seiyaku Pain Management Drugs Revenue (US$, Mn), (2016-2021)
Table 63. Teva Corporate Summary
Table 64. Teva Pain Management Drugs Product Offerings
Table 65. Teva Pain Management Drugs Revenue (US$, Mn), (2016-2021)
Table 66. J&J Corporate Summary
Table 67. J&J Pain Management Drugs Product Offerings
Table 68. J&J Pain Management Drugs Revenue (US$, Mn), (2016-2021)
Table 69. Assertio Therapeutics Corporate Summary
Table 70. Assertio Therapeutics Pain Management Drugs Product Offerings
Table 71. Assertio Therapeutics Pain Management Drugs Revenue (US$, Mn), (2016-2021)
Table 72. Allergan Corporate Summary
Table 73. Allergan Pain Management Drugs Product Offerings
Table 74. Allergan Pain Management Drugs Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Pain Management Drugs Segment by Type
Figure 2. Pain Management Drugs Segment by Application
Figure 3. Global Pain Management Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Pain Management Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Pain Management Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pain Management Drugs Revenue in 2020
Figure 8. By Type - Global Pain Management Drugs Revenue Market Share, 2016-2027
Figure 9. By Application - Global Pain Management Drugs Revenue Market Share, 2016-2027
Figure 10. By Region - Global Pain Management Drugs Revenue Market Share, 2016-2027
Figure 11. By Country - North America Pain Management Drugs Revenue Market Share, 2016-2027
Figure 12. US Pain Management Drugs Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Pain Management Drugs Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Pain Management Drugs Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Pain Management Drugs Revenue Market Share, 2016-2027
Figure 16. Germany Pain Management Drugs Revenue, (US$, Mn), 2016-2027
Figure 17. France Pain Management Drugs Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Pain Management Drugs Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Pain Management Drugs Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Pain Management Drugs Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Pain Management Drugs Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Pain Management Drugs Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Pain Management Drugs Revenue Market Share, 2016-2027
Figure 24. China Pain Management Drugs Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Pain Management Drugs Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Pain Management Drugs Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Pain Management Drugs Revenue, (US$, Mn), 2016-2027
Figure 28. India Pain Management Drugs Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Pain Management Drugs Revenue Market Share, 2016-2027
Figure 30. Brazil Pain Management Drugs Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Pain Management Drugs Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Pain Management Drugs Revenue Market Share, 2016-2027
Figure 33. Turkey Pain Management Drugs Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Pain Management Drugs Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Pain Management Drugs Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Pain Management Drugs Revenue, (US$, Mn), 2016-2027
Figure 37. GSK Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Pfizer Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Grunenthal Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Sanofi Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Bayer Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. AstraZeneca Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Eli Lilly Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Endo Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Merck Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Yunnan Baiyao Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Teikoku Seiyaku Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Teva Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. J&J Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Assertio Therapeutics Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Allergan Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global Pain Management Drugs Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93
    Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......
  • Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......
  • Global Opioids Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......
  • Global Methadone Hydrochloride Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......
  • Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......
  • Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111
    According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......
  • Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87
    According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......
  • Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131
    According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......
  • Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167
    The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs